GERN vs REGN: Which Stock is Better?

Side-by-side comparison of Geron Corp and Regeneron Pharmaceuticals Inc in 2026

Comparison Updated:

GERN

Geron Corp

$1.66

REGN

Regeneron Pharmaceuticals Inc

$761.85

Key Metrics Comparison

MetricGERNREGNWinner
Market Cap$1.06B$82.17BREGN
P/E RatioN/A18.72REGN
EPS (TTM)$N/A$41.51REGN
Revenue Growth0.0%0.0%REGN
Gross Margin97.4%44.6%GERN

Analyze GERN

Full quant analysis

Analyze REGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is GERN or REGN a better investment?

Comparing GERN and REGN: Geron Corp has a market cap of $1.06B while Regeneron Pharmaceuticals Inc has $82.17B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between GERN and REGN?

GERN (Geron Corp) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: GERN or REGN?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: GERN or REGN?

REGN has higher revenue growth at 0.0% vs 0.0% for GERN.

Which company is more profitable: GERN or REGN?

Geron Corp (GERN) has higher gross margins at 97.4% compared to 44.6% for REGN.

Which is the larger company: GERN or REGN?

Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $82.17B compared to $1.06B for GERN.

Should I buy GERN or REGN in 2026?

Both GERN and REGN have investment merit. GERN trades at $1.66 while REGN trades at $761.85. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between GERN and REGN stock?

Key differences: Market Cap ($1.06B vs $82.17B), P/E Ratio (N/A vs 18.7x), Revenue Growth (0.0% vs 0.0%), Gross Margin (97.4% vs 44.6%).

Popular Stock Comparisons